Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-02-18
1999-10-12
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514255, A61K 3156, A61K 31495
Patent
active
059655496
ABSTRACT:
The invention is directed to an aqueous non-ototoxic, topical, otic pharmaceutical composition of matter for treating a mammal consisting essentially of: ciprofloxacin or a pharmaceutically acceptable salt thereof in aqueous solution in an amount effective for antibacterial action; hydrocortisone or a pharmaceutically acceptable salt thereof in an amount effective as an anti-inflammatory agent; polyvinyl alcohol at least about 85% hydrolyzed in an amount effective to suspend the hydrocortisone in solution; water sufficient to produce an aqueous composition; benzyl alcohol in an amount effective for antibacterial action; lecithin in an amount effective for enhancing suspension of other constituents in the composition; and polysorbate ranging from polysorbate 20 to 80 in an amount effective for spreading the preparation on a hydrophobic skin surface to the site of infection or inflammation.
REFERENCES:
patent: 4025620 (1977-05-01), Beyer et al.
patent: 4670444 (1987-06-01), Grohe
patent: 4844902 (1989-07-01), Grohe et al.
patent: 4957922 (1990-09-01), Lammens et al.
patent: 5023257 (1991-06-01), Pollinger et al.
patent: 5061729 (1991-10-01), Kincses et al.
patent: 5260073 (1993-11-01), Phipps
patent: 5271939 (1993-12-01), Robertson et al.
patent: 5422116 (1995-06-01), Yen et al.
Strauss, M., et al., Otitis Externa Associated With Aquatic Activities (Swimmer's Ear), Clinics in Dermatology, 1987, pp. 103-111.
Stange, G., et al., Laryngol Rhino Otol 68 (12):653-656 (1989) [Abstract].
Stange, G., et al., Laryngol Rhino Otol 68(12):653-656 (1989).
Esposito, S., et al., Topical and Oral Treatment of Chronic Otitis Media With Ciprofloxacin, Arch Otolaryngol Head Neck Surg--vol. 116, 1990, pp. 557-559.
Garcia-Rodriguez, J.A., et al., Efficacy of 2 Regimens of Local Ciprofloxacin in the Treatment of Ear Infections, Preprint: Drugs 45 (Suppl.), 1993, pp. 40-41.
Ganz, H., Bacterial Otitis Externa Beyond the Organ Limits--Systemic and Topical Combination Treatment with Ciprofloxacin, pp. 2-7 (translation from German).
Garcia-Rodriguez, J.A., Efficacy of Topical Ciprofloxacin in the Treatment of Ear Infections in Adults, J Antimicrob Chemother, 1993, pp. 31:452-453.
Esposito, S., et al., Topical Cirpofloxacin (CP) Versus Parenteral Gentamicin (GM) in Pseudomonas Infections of the Middle Ear, 29. Interscience Conference An Timicrobiotic Agents Chemotherapy +* Houston, 545 (1989) [Abstract].
Goldman David
Purwar Shivaji
Bayer Aktiengesellschaft
Fay Zohreh
Gray William F.
Jones Huw R.
LandOfFree
Ciprofloxacin-hydrocortisone suspension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ciprofloxacin-hydrocortisone suspension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ciprofloxacin-hydrocortisone suspension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652590